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Abstract
Background: Leukemia is one of the most life-threatening cancers today, and acute promyelogenous leukemia
(APL) is a common type of leukemia. Many natural compounds have already been found to exhibit significant anti-
tumor effects. Lycorine, a natural alkaloid extracted from Amaryllidaceae, exhibited anti-leukemia effects in vitro and
in vivo. The survival rate of HL-60 cells exposed to lycorine was decreased, cell growth was slowed down, and cell
regeneration potential was inhibited. HL-60 cells exhibited typical apoptotic characteristic. Lycorine can suppress
leukemia growth and reduce cell survival and inducing apoptosis of tumor cells. The purpose of this work is to
elucidate the mechanism by which lycorine induces APL cells.
Results: When HL-60 cells were treated with different concentration of lycorine, the expression of p21 and TNF-a
was up-regulated in a concentration-dependent manner as shown by real-time quantitative reverse transcriptase-
polymerase chain reaction and Western blotting. Lycorine also down-regulated p21-related gene expression,
including Cdc2, Cyclin B, Cdk2 and Cyclin E, promoted Bid truncation, decreased IB phosphorylation and blocked
NF-B nuclear import. Cytochrome c was released from mitochondria as observed with confocal laser microscopy.
Conclusions: The TNF-a signal transduction pathway and p21-mediated cell-cycle inhibition were involved in the
apoptosis of HL-60 cells induced by lycorine. These results contribute to the development of new lycorine-based
anti-leukemia drugs.
Background
A tumor is a disease with two defining characteristics: a
proliferation disorder and an apoptosis obstacle. The
inhibition of proliferation and the induction of apoptosis
are regulated by a network of signaling pathways and
transcription factors, which may represent potential tar-
gets for rational tumor therapy [1,2]. Apoptotic events
are regulated by the interplay of proapoptotic and antia-
poptotic proteins. The apoptotic pathways include two
major signaling pathways: the death receptor-induced
pathway and the mitochondria-apoptosome-mediated
pathway. Elements of the death receptor pathway
include cell death ligands and their receptors, such as
tumor necrosis factor (TNF) and tumor necrosis factor-
related apoptosis-inducing ligand (TRAIL) receptor, and
downstream molecules, such as caspase 8. The major
components of the mitochondrial pathway include apop-
totic stimuli, mitochondria, the apoptosome, and key
effector caspases [1]. Crosstalk between these two apop-
totic pathways is mediated through the truncation of the
BH3-interacting death domain (Bid) protein. Inhibitors
of apoptosis proteins include the X-linked inhibitor of
apoptosis protein (XIAP), the cellular inhibitor of apop-
tosis protein (cIAP), survivin, and the phosphatidyl ino-
sitol 3 kinase/serine/threoninespecific protein kinase/
nuclear factor-kappa B (PI3K/AKT/NF-B) pathway.
Recent studies had focused on inducing cancer cell
apoptosis by targeting the core components of the apop-
tosis-related signaling pathway and had produced pro-
mising results [3,4]. Cancer is also a disease of the cell
cycle, a series of events that a eukaryotic cell must
undergo to result in its replication. The cyclin-depen-
dent kinase inhibitor p21 plays a key role in cell-cycle
regulation. Gartel and Tyner [5] showed that p21-
dependent cell cycle arrest occurs at the G2/M phase.
The key regulator of the G2/M phase is the cell division
cycle 2 (Cdc2)/Cyclin B, the activity of which can be
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regulated by p21 [6]. Furthermore, p21 possesses proa-
poptotic functions in some systems. Overexpression of
p21 increases the susceptibility of glioma cell lines [7]
and several p53-deficient human cell lines [8] to che-
motherapeutic agent-induced apoptosis. These studies
had revealed a correlation between the expression level
of p21 and patient survival [9].
Alkaloids have been found to exhibit effective anti-
cancer activities with multiple mechanisms. For
example, camptothecin and its analogs exhibited strong
anti-cancer activities by inhibiting the DNA-uncoiling
function of topoisomerase I [10]. Shikonin induced the
apoptosis of Bcr/Abl-positive chronic myelogenous leu-
kemia (CML) cells through a reactive oxygen species/
c-Jun N-terminal kinase (ROS/JNK)-mediated process
[11]. Homoharringtonine promoted apoptosis in K562
cells [12] and more than 90% of the leukaemic stem
cells were killed after treatment with homoharringtonine
in vitro [13]. Leukemia is one of the most life-threaten-
ing hematological malignant cancers. Because of its
potential sensitivity to chemical reagents [14,15], scien-
tists are attempting to discover new specific and effec-
tive chemical drugs to fight this disease [16]. Lycorine,
an alkaloid extracted from Amaryllidaceae, has multiple
pharmacological functions, such as anti-virus effects,
anti-tumour effects, and emetic action [17,18]. In our
previous work, we found that lycorine decreased the
survival rate and inducing apoptosis in leukemia and
multiple myeloma cell lines[19,20], and the mechanisms
of induced apoptosis have mediated by stimulating the
caspase pathway and increasing the Bax:Bcl-2 ratio
through the down-regulation of Bcl-2 expression. In
addition, lycorine induced apoptosis in human leukemia
cells via the mitochondria pathway and caused a rapid
turnover of myeloid cell leukemia 1 (Mcl-1) protein,
which occurred before caspase activation [21]. Lycorine
exerted its in vitro antitumor activity through cytostatic
rather than cytotoxic effects. Also, lycorine provided sig-
nificant therapeutic benefit in mice bearing brain grafts
of the B16F10 melanoma model at nontoxic doses [22].
Lycorine exhibited in vivo anti-tumor activity when
tested in SCID mice model with human acute promyelo-
cytic leukemia (APL) cells and was a useful therapy
against [23]. The human leukemia (Jurkat) cells were
investigated with the treatment of synthetic and natural
lycorane alkaloids. The results showed that a free ring-C
1,2-diol in the lycorine series (lycorine and pseudolycor-
ine) was required for potent apoptosis-inducing activity
[24]. The aim of this study was to investigate the mole-
cular mechanism underlying lycorine-induced death of
HL-60 cells and provide a mechanistic framework for
further exploring the use of lycorine as a novel anti-
leukemia agent.
Results
Up-regulation of p21 expression and down-regulation of
its regulated genes
Up-regulation of the p21 gene was detected with real-
time quantitative RT-PCR when HL-60 cells were trea-
ted with 5.0 μM lycorine (Fig. 1A). Western blotting
(Fig. 1A, B) also showed that lycorine significantly up-
regulate p21 mRNA and protein in a concentration-
dependent manner. Because p21 regulated the activity of
Cdc2-Cyclin B and Cdk2-Cyclin E, and the expression
of Cdc2, Cyclin B, Cdk2, and Cyclin E could be detected
by Western blotting. Results showed that these proteins
were significantly down-regulated in a concentration-
dependent manner after treatment with lycorine
(Fig. 1C and 1D).
Up-regulation of TNF-a and increase of truncated Bid
(tBid)
The results of real-time RT-PCR and Western blotting
(Fig. 2A and 2B) revealed that the expression of TNF-a
was significantly up-regulated in a concentration-depen-
dent manner in HL-60 cells treated with 5.0 μM lycor-
ine for 24 h. Furthermore, Western blotting showed that
the expression level of Bid protein was decreased when
the lycorine concentration reached 5.0 μM and that the
expression level of truncated Bid (tBid) was significantly
increased in a concentration-dependent manner
(Fig. 2C).
Effect of lycorine on cytochrome c release
tBid may promote the release of cytochrome c and sub-
sequent activation of caspase 9 and caspase 3, which in
turn leads to cell apoptosis. We examined the subcellu-
lar localisation of cytochrome c to determine whether
cytochrome c was released from the mitochondria into
the cytosol when lycorine initiates the apoptosis path-
way. Immunofluorescence of cytochrome c was visua-
lized with a confocal laser microscope. In both groups
of cells (the experimental group and the control group),
the nucleus appeared blue when the DNA was stained
with Hoechst 33258 (Fig. 3A2, 3B2) and the cytochrome
c appeared red when stained with cyanine 3 (Cy3) fluor-
ochrome (Fig. 3A1, B1). After the cells were treated
with 5 μM lycorine for 24 h, the staining patterns of
cytochrome c became diffuse and blurred (Fig. 3B1) in
contrast to the compact, plaque-like appearance of cyto-
chrome c in the control group (Fig. 3A1), indicating the
translocation of cytochrome c from the mitochondria
into the cytosol in the treated cells. We also found that
some red dye had entered the nucleus and mixed with
the blue stain to yield a purple-stained nucleus
(Fig. 3B3).
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Figure 1 Effects of lycorine on expression of p21 and downstream genes regulated by p21 in HL-60 cells. (A) Expression levels of p21 in
HL-60 cells were analysed by real-time quantitative RT-PCR. Expression levels were standardised using expression of the housekeeping gene b-
actin. (B) Effects of lycorine on expression of p21 protein, (C) Cdc2 and Cyclin B proteins, (D) Cdk2 and Cyclin E proteins. a-tubulin was used for
normalisation and verification of the protein loading in B, C, and D in Western blotting. Lanes 1-4, HL-60 cells were treated with 0, 1.25, 2.5, and
5.0 μM lycorine, respectively. Results were presented as mean ± S.D. (n = 3, three independent experiments). Asterisk symbol (*) indicates
significant difference (p < 0.05) compared with the control group.
Liu et al. Cancer Cell International 2010, 10:25
http://www.cancerci.com/content/10/1/25
Page 3 of 9
Figure 2 Effects of lycorine on expression of TNF-a and truncation of Bid in HL-60 cells. (A) Expression levels of TNF-a in HL-60 cells were
analysed by real-time quantitative RT-PCR. Expression levels were standardised using expression of the housekeeping gene b-actin. (B) Effect of
lycorine on expression of TNF-a protein, (C) Bid and truncation of Bid. a-tubulin was used for normalisation and verification of the protein
loading in B and C in Western blotting. Lanes 1-4, HL-60 cells were treated with 0, 1.25, 2.5, and 5.0 μM lycorine, respectively. Results were
presented as mean ± S.D. (n = 3, three independent experiments). Asterisk symbol (*) indicates significant difference (p < 0.05) compared with
the control group.
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Inhibition of IB phosphorylation and blockade of NF-B
nuclear import
The expression levels of IB and NF-B were not
obviously changed in HL-60 cells treated with lycorine;
however, the phosphorylation level of IB was signifi-
cantly decreased when the concentration of lycorine
reached 5.0 μM (Fig. 4A and 4B). To investigate the
localization and nuclear import of NF-B, nuclear pro-
teins were extracted from HL-60 cells treated with dif-
ferent concentrations of lycorine and subsequent
Western blotting was performed. The results showed
that the expression of NF-B protein in the nucleus
decreased significantly in HL-60 cells (Fig. 4C).
Immunocytochemistry results showed that lycorine sig-
nificantly blocked the nuclear import of NF-B protein.
A comparison of treated and untreated cells revealed
that NF-B was mainly distributed in the cytoplasm of
the HL-60 cells treated with lycorine (Fig. 4D4, D6),
whereas NF-B was mainly distributed in the nucleus of
untreated HL-60 cells (Fig. 4D1, D3).
Discussion
Studies reported changes in gene expression of p21 can
prohibit cell proliferation and induce cell apoptosis
[25,26]. p21, a key member of the Cip/Kip family and a
cyclin-dependent kinase inhibitor, can bind to and
directly inhibit the activity of Cyclin E-Cdk2 and Cyclin
B-Cdc2 [6,27,28]. Overexpression of p21 can lead to cell
cycle progression at G1, G2/M or S-phase arrest. The
expression of p21 is tightly controlled by the tumour
suppressor protein p53, through which this protein
mediates the p53-dependent cell-cycle arrest at G1
phase in response to a variety of stress stimuli [29]. We
discovered that p21 was up-regulated in HL-60 cells
treated with lycorine and that both Cyclin B-Cdc2 and
Cyclin E-Cdk2 were significantly down-regulated follow-
ing lycorine treatment. Our findings suggested that
lycorine regulated the expression of p21, and then influ-
enced the expression of down-stream genes Cyclin B-
Cdc2 and Cyclin E-Cdk2, resulting in cell cycle arrest in
HL-60 cells. Because p21 has been shown to possess
proapoptotic functions in p53-deficient systems [5,8], we
hypothesized that p21 also functions as a proapoptotic
molecule in the HL-60 cell line, a p53-deficient leuke-
mia cell line. Our recent research results showed that
p21 was also up-regulated after lycorine treated in K562
cell line (data not shown), a p53-indeficient leukemia
cell line. Thus it implies that the up-regulation of p21
go through p53-independent pathways, and it is possible
that p21 acts as a direct target after lycorine treatment.
In the further, it is very necessary to silence p21 to con-
firm whether p21 is the direct target of lycorine in HL-
60 cells and figure out the upstream factors by which
up-regulate p21.
Our results showed that the expression of TNF-a was
up-regulated in HL-60 cells treated with lycorine. It
means the TNF-a signaling pathway played an impor-
tant role in apoptosis induced by lycorine. Furthermore,
we discovered that lycorine promoted the truncation of
Bid protein, which can promote the release of cyto-
chrome c from mitochondria [30] and, ultimately, cell
apoptosis. We previously showed that lycorine pro-
moted the release of cytochrome c and increased the
activities of caspases 3, 8, and 9 in HL-60 cells and
KM3 cells. Thus, we conclude that both the death-
receptor-induced pathway and the mitochondria-apop-
tosome-mediated pathway were involved in the lycor-
ine-induced apoptosis in HL-60 cells and that the Bid
protein mediated the crosstalk between these two apop-
totic pathways. p21 may also play an key role in apopto-
sis induced by activation of members of the TNF death
receptor family [31].
NF-B, an important transcription factor, regulates the
transcription of many genes related to immune and
inflammatory responses, cell differentiation, and apopto-
sis when transported into the cell nucleus [32]. An NF-
B-binding region was found within the upstream pro-
moter region of several members of the Bcl2 family [33].
When NF-B combined with IB in the cytoplasm,
Figure 3 Effect of lycorine on cytochrome c release. Cells were
fixed and labelled for cytochrome c (red) and DNA (blue). (A) HL-60
cells in control group. (B) Cells were treated with 5.0 μM lycorine for
24 h. Cell nuclei were observed by DNA staining with DAPI (A2, B2).
The staining pattern of cytochrome c became diffusive in most cells
(B1), consistent with a translocation of cytochrome c into the
cytosol and nucleus (B3), whereas cytochrome c displayed a dotted
pattern in untreated cells, consistent with its location within
mitochondria (A1, A3). Images were obtained with a confocal
microscope (×400).
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Figure 4 Effects of lycorine on phosphorylation of IB and nuclear import of NF-B. (A) Effect of lycorine on expression of IB and
phosphorylation of IB protein. (B) Effect of lycorine on expression of NF-B protein and (C) distribution of NF-B protein in nucleus. a-tubulin
was used for normalisation and verification of the protein loading in A, B, and C in Western blotting. Lanes 1-4: HL-60 cells were treated with 0,
1.25, 2.5, and 5.0 μM lycorine, respectively. (D) Subcellular distribution of NF-B detected by immunofluorescence staining. HL-60 cells were
treated with 0 μM (D1, D2, D3) and 5.0 μM lycorine (D4, D5, D6), respectively. Cells were labeled for NF-B (red) and DNA (blue). Cell nuclei were
stained by DAPI (D2, D5). NF-B was mainly distributed in the cytoplasm (D4, D6) in the HL-60 cells treated with lycorine, whereas NF-B was
mainly distributed in the nucleus in untreated cells (D1, D3). Results were presented as mean ± S.D. (n = 3, three independent experiments).
Asterisk symbol (*) indicates significant difference (p < 0.05) compared with the control group.
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NF-B lost its ability to regulate transcription. However,
when IB was phosphorylated and released from the
IB-NF-B complex, NF-B regained this ability [34]. In
this study, we found that lycorine decreased the phos-
phorylation of IB in HL-60 cells, thus blocking the
nuclear import of NF-B. This finding indicates that the
NF-B signaling pathway was inhibited when lycorine
induced HL-60 cell apoptosis.
From our results, we can deduce that cell apoptosis
induced by lycorine is a very complex process involving
the interaction of multiple signal transduction pathways
and it deserves further study.
Conclusions
The TNF-a signalling transduction pathway and
p21-mediated cell-cycle prohibition were involved in
lycorine-induced death of HL-60 cells. These results may
help in the development of new anti-leukemia drugs.
Methods
Cell culture and lycorine treatment
The human acute promyelocytic leukemia (APL) cell
line HL-60 (ATCC Number: CCL-240) was cultured in
RPMI-1640 medium containing 10% fetal bovine serum
(FBS), 100 U/ml penicillin, and 100 mg/L streptomycin
at 37°C with 5% CO2 and saturated humidity. When the
cell density reached 5 × 105 to 1 × 106/ml, the cells of
the experimental group were treated with lycorine,
untreated cells represented the control.
RNA extraction and real-time RT-PCR analyses
Total cellular RNA was extracted with Trizol reagent
(Invitrogen, Carlsbad, CA, USA) from cells treated with
various concentrations of lycorine (0, 1.25, 2.5, 5.0 μM)
for 24 hours. Real-time quantitative reverse transcrip-
tase-polymerase chain reaction (RT-PCR) was performed
to detect the gene expression of p21 and TNF-a, and b-
actin was used as the internal standard reference. The
primer sequences, which were designed using Primer 5
software in accordance with the GenBank sequence, are
listed in Table 1. 1.0 μg of total RNA of each group and
0.5 μg of oligo (dT)16 were added to an eppendorf tube
and incubated at 65°C for 5 min. Then the reaction sys-
tem volume was adjusted to 20 μl by adding 4.0 μl of
5× MMLV RT buffer, 20 units of RNasin, 1.0 μl of
dNTPs (10 mmol), and 10 units of MMLV reverse tran-
scriptase; incubated at 42°C for 60 min; and kept at 75°
C for 5 min to terminate the reaction. The PCR reaction
system (20 μl) was prepared by mixing 10 μl of SYBR
premix Ex Taq DNA Polymerase (Takara), 2 μl of
reverse transcription products, and 10 pmol mixtures of
the upstream and downstream primers and distilled
water. The PCR mixture was denatured at 95°C for 10 s,
and amplification was run at 95°C for 15 s, 56°C for 20
s, and 68°C for 20 s for 40 cycles in the Mastercycler
Realplex2 (Eppendorf).
Western blotting
Exponentially growing HL-60 cells (2 × 106) were trea-
ted with various concentrations of lycorine (0, 1.25, 2.5,
5.0 μM) for 24 h. The cells were then collected and
lysed with 100 μl of RIPA buffer (20 mM Tris-HCl, pH
7.5; 150 mM NaCl, 1 mM EDTA, 1% Nonidet P40, 0.5%
deoxycholate, 0.1% SDS, 5 mM NaF, and 0.1 mg/ml
PMSF), and centrifuged at 13000 rpm at 4°C for 15 min
to collect the supernatant. Nuclear proteins were
extracted from HL-60 cells by using NE-PER® Nuclear
and Cytoplasmic Extraction Reagents according to com-
pany procedure (Pierce). Protein concentrations were
measured with the BCA protein assay kit (Pierce). Equal
amounts of protein (50 μg) from each group were sepa-
rated by 12% SDS-PAGE and then transferred to a
PVDF membrane (Millipore) by blotting on semi-dry
electroblotter for 1 h at 4°C. Membranes were blocked
in PBS with 0.1% Tween 20 (PBST) containing 5% non-
fat dried milk power for 1 h, then incubated 2 h with
desired primary antibodies at room temperature. After 3
times washes, the blot was incubated with anti-mouse
or anti-rabbit IgG coupled to HRP second antibodies for
1 h at room temperature. After 3 times washes, blots
were developed with a chemiluninescene detection kit
(ECL; Pierce). The optical density of each band was
quantified by densitometric scanning.
Immunofluorescence staining
Immunofluorescence staining was used to analyze the
subcellular distribution of cytochrome c and NF-B in
HL-60 cells induced by lycorine. Cells were collected
after treatment with 5.0 μM lycorine or without lycorine
for 8 h (for check cytochrome c) or 24 h (for check NF-
B), Cell pellets were smeared on a slide and fixed with
4% formaldehyde for 30 min. Non-specific antigens were
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blocked with normal serum diluted 1:20 in PBS for
10 min at room temperature. For staining cytochrome c,
cells were incubated with the diluted mouse anti-cyto-
chrome c antibody (BioVision) for 2 h and washed 3
times (5 min per wash) with PBS buffer, then incubated
with goat anti-mouse Cy3 antibody (Biomeda) for 1 h at
room temperature. For staining NF-B, cells were incu-
bated for 2 h with mouse anti-NF-B antibody and
washed 3 times with PBS buffer, then cells were incu-
bated with biotin-labeled rabbit anti-mouse antibody for
1 h and washed 3 times with PBS buffer. Finally, the
cells were treated with streptavidin-biotin complex
(SABC)-Cy3 reagent. DNA was stained with 1 μg/ml of
4’,6-diamidino-2-phenylindole (DAPI) to locate the
nucleus. The images were obtained using confocal laser
microscopy (Nikon) with excitation light at a wavelength
of 554 nm.
Statistical analysis
The statistical difference between the groups was deter-
mined by AVOVA and Tukey’s Studentized Range test.
Differences among groups were considered statistically
different at P < 0.05.
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